These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1922314)

  • 41. Adolescent drug use: suggestions for future research.
    Krasnegor NA
    NIDA Res Monogr; 1988; 77():128-34. PubMed ID: 3145425
    [No Abstract]   [Full Text] [Related]  

  • 42. Preventing adolescent substance abuse through drug education.
    Moskowitz JM
    NIDA Res Monogr; 1983; 47():233-49. PubMed ID: 6419117
    [No Abstract]   [Full Text] [Related]  

  • 43. Substance abuse: an overview.
    Comerci GD; Schwebel R
    Adolesc Med; 2000 Feb; 11(1):79-101. PubMed ID: 10640340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Developmental epidemiological studies of substance use in Woodlawn: implications for prevention research strategy.
    Kellam SG; Brown CH; Fleming JP
    NIDA Res Monogr; 1982 Apr; 41():21-33. PubMed ID: 6811911
    [No Abstract]   [Full Text] [Related]  

  • 45. [The primary prevention of drug abuse].
    González García A
    Rev Sanid Hig Publica (Madr); 1980; 54(11-12):1217-41. PubMed ID: 7348351
    [No Abstract]   [Full Text] [Related]  

  • 46. You can do something about adolescent substance use & abuse: a practitioner's guide to adolescent alcohol and other drug prevention.
    Johnson NP; Stands BO; Strothers HS
    J S C Med Assoc; 1994 Dec; 90(12):601-5. PubMed ID: 7869697
    [No Abstract]   [Full Text] [Related]  

  • 47. Testing theory through developmental epidemiologically based prevention research.
    Kellam SG
    NIDA Res Monogr; 1994; 139():37-57. PubMed ID: 8742550
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of drug use outcome expectancies in substance abuse risk: an interactional-transformational model.
    Leventhal AM; Schmitz JM
    Addict Behav; 2006 Nov; 31(11):2038-62. PubMed ID: 16616433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Examining conceptual models for understanding drug use behavior among American Indian youth.
    King J; Thayer JF
    NIDA Res Monogr; 1993; 130():129-43. PubMed ID: 8413504
    [No Abstract]   [Full Text] [Related]  

  • 50. The theoretical model: diagnostic assessment and placement in prevention treatment mode by school personnel.
    Sullivan AP; Guglielmo R; Polak R
    J Drug Educ; 1987; 17(1):59-67. PubMed ID: 3585649
    [No Abstract]   [Full Text] [Related]  

  • 51. Child and adolescent drug use: a judgement and information processing perspective to health-behavior interventions.
    Cvetkovich G; Earle TC; Schinke SP; Gilchrist LD; Trimble JE
    J Drug Educ; 1987; 17(4):295-313. PubMed ID: 3430278
    [No Abstract]   [Full Text] [Related]  

  • 52. [Causes of adolescent drug use].
    Kury H; Patzschke H
    Prax Kinderpsychol Kinderpsychiatr; 1979 Jul; 28(5):176-87. PubMed ID: 493241
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevention evaluation research methods: findings and consensus.
    Leukefeld CG; Bukoski WJ
    NIDA Res Monogr; 1991; 107():264-71. PubMed ID: 1922310
    [No Abstract]   [Full Text] [Related]  

  • 54. Qualitative methodological issues in drug user research.
    Valdez A; Sifaneck SJ
    Subst Use Misuse; 2010 Apr; 45(5):645-7. PubMed ID: 20222776
    [No Abstract]   [Full Text] [Related]  

  • 55. Drug abuse prevention--the sponsoring foundations' perspective.
    Tarlov AR; Rimel RW
    J Sch Health; 1986 Nov; 56(9):358. PubMed ID: 3640924
    [No Abstract]   [Full Text] [Related]  

  • 56. Experimental and quasi-experimental designs in prevention research.
    Snow DL; Tebes JK
    NIDA Res Monogr; 1991; 107():140-58. PubMed ID: 1922303
    [No Abstract]   [Full Text] [Related]  

  • 57. [The Scandinavian Drug Research Authority's last will. Interdisciplinary research should strengthen the basis for preventive measures. Interview by Karlsson Y].
    Bruun K; Wickberg N
    Nord Med; 1979 Oct; 94(10):249-51. PubMed ID: 492941
    [No Abstract]   [Full Text] [Related]  

  • 58. Neurologically plausible distinctions in cognition relevant to drug use etiology and prevention.
    Stacy AW; Ames SL; Knowlton BJ
    Subst Use Misuse; 2004; 39(10-12):1571-623. PubMed ID: 15587946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The most critical unresolved issues associated with transdisciplinary substance use prevention research: programs, models, paradigms, concepts, and processes.
    Spruijt-Metz D; Chou CP
    Subst Use Misuse; 2004; 39(10-12):2071-2. PubMed ID: 15587958
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of drug taking behaviour. Some theoretical and methodological considerations.
    Waal H; Holsten F
    Acta Psychiatr Scand; 1980 Feb; 61(2):127-34. PubMed ID: 7361585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.